Upgrade to SI Premium - Free Trial

Amneal Pharmaceuticals (AMRX)

13.71 -0.04 (0.29%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Amneal reports positive interim results for Parkinson's drug CREXONT June 5, 2026 8:00 AM - StreetInsider Amneal reports positive interim results for CREXONT in Parkinson's study June 5, 2026 8:00 AM - StreetInsider Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease June 5, 2026 8:00 AM - Globe NewsWire Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease June 5, 2026 8:00 AM - StreetInsider Amneal receives FDA approval for romidepsin injection solution June 4, 2026 8:00 AM - StreetInsider Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution June 4, 2026 8:00 AM - StreetInsider Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 1, 2026 8:00 AM - StreetInsider Amneal Pharmaceuticals (AMRX) PT Raised to $16 at Barclays May 20, 2026 4:19 AM - StreetInsider Form 4 Amneal Pharmaceuticals, For: May 11 Filed by: Autor Deborah M. May 12, 2026 4:11 PM - SEC Filing Form 144 Amneal Pharmaceuticals, Filed by: Autor Deborah M. May 11, 2026 6:57 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: BUCHI J KEVIN May 8, 2026 4:29 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Autor Deborah M. May 8, 2026 4:28 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: George Jeffrey P. May 8, 2026 4:28 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Patel Gautam May 8, 2026 4:27 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Kiely John May 8, 2026 4:24 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Nark Ted C May 8, 2026 4:24 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: MEISTER PAUL M May 8, 2026 4:23 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Yanai Shlomo May 8, 2026 4:22 PM - SEC Filing Form 10-Q Amneal Pharmaceuticals, For: Mar 31 May 7, 2026 4:27 PM - SEC Filing Form 8-K Amneal Pharmaceuticals, For: May 06 May 7, 2026 4:18 PM - SEC Filing Form 8-K Amneal Pharmaceuticals, For: May 07 May 7, 2026 4:10 PM - SEC Filing Amneal Reports First Quarter 2026 Financial Results May 7, 2026 4:01 PM - StreetInsider Form SCHEDULE 13G Amneal Pharmaceuticals, Filed by: BlackRock, Inc. April 27, 2026 4:15 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 23, 2026 7:10 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 22, 2026 5:00 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 22, 2026 4:29 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 22, 2026 4:26 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 22, 2026 4:25 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 22, 2026 4:25 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, April 22, 2026 6:24 AM - SEC Filing Form 8-K Amneal Pharmaceuticals, For: Apr 22 April 22, 2026 6:23 AM - SEC Filing Amneal Pharmaceuticals to acquire Kashiv BioSciences in biosimilar deal April 22, 2026 6:17 AM - StreetInsider Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader April 22, 2026 6:17 AM - BizWire Amneal agrees to acquire Kashiv BioSciences for $750 million April 22, 2026 6:00 AM - StreetInsider Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance April 22, 2026 6:00 AM - Globe NewsWire Amneal reports positive interim results for CREXONT in Parkinson's study April 20, 2026 8:02 AM - StreetInsider Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® April 20, 2026 8:00 AM - Globe NewsWire UBS Starts Amneal Pharmaceuticals (AMRX) at Buy April 17, 2026 3:05 AM - StreetInsider Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. April 14, 2026 8:01 AM - Globe NewsWire Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% April 9, 2026 8:00 AM - Globe NewsWire Amneal to Report First Quarter 2026 Results on May 1, 2026 April 7, 2026 4:01 PM - StreetInsider Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month April 7, 2026 12:36 PM - Globe NewsWire Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month April 7, 2026 8:14 AM - StreetInsider Form 4/A Amneal Pharmaceuticals, For: Mar 02 Filed by: Patel Chintu March 27, 2026 4:21 PM - SEC Filing Form 4/A Amneal Pharmaceuticals, For: Mar 02 Filed by: Patel Chirag K. March 27, 2026 4:20 PM - SEC Filing Form SCHEDULE 13D/A Amneal Pharmaceuticals, Filed by: Patel Dipan March 26, 2026 6:23 PM - SEC Filing Form SCHEDULE 13G/A Amneal Pharmaceuticals, Filed by: VANGUARD GROUP INC March 26, 2026 3:45 PM - SEC Filing Form DEFA14A Amneal Pharmaceuticals, March 25, 2026 4:18 PM - SEC Filing Form DEF 14A Amneal Pharmaceuticals, For: May 06 March 25, 2026 4:17 PM - SEC Filing Full Article List